{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-067181","form_type":"8-K","ticker":"ZURA","cik":"0001855644","company_name":"Zura Bio Ltd","filed_at":"2023-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.285415+00:00","generated_at":"2026-06-14T08:32:50.545552+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Zura Bio shareholders approve $64M private placement and equity plan expansion","bullets":["Issuance of 15,073,530 shares (including 3,782,000 pre-funded warrants) for ~$64M approved; closing June 5.","Chairman Amit Munshi to receive 117,647 shares and options for 1,130,000 shares under Equity Compensation Proposal.","Equity Incentive Plan increased by 5,564,315 shares to total 9,594,213 shares, plus annual 5% evergreen increase.","Combined with $16M issued May 1, total placement exceeds 20% of outstanding shares at a discount to Nasdaq's Minimum Price."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-067181","json":"https://secwatch.observer/filing/0001104659-23-067181.json","markdown":"https://secwatch.observer/filing/0001104659-23-067181.md","text":"https://secwatch.observer/filing/0001104659-23-067181.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923067181/0001104659-23-067181-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923067181/tm2317576d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T08:32:50.545552+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"887356e79f4d77a22b155055c56a8456158ddce5","claim":"Zura Bio Ltd shareholders approved Equity Compensation Proposal - issuance and grant of options to Amit Munshi at the 2023-06-01 meeting.","evidence_excerpt":"The voting results of the Ordinary Shares were as follows: Votes For Votes Against Abstentions 21,823,616 1,400 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923067181/0001104659-23-067181-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-01"}],"fact_type":"shareholder_vote"},{"claim_id":"98ef4f70b4e683ab73d007e3ec59ac9bc250bb4e","claim":"Zura Bio Ltd shareholders approved EIP Amendment Proposal - amend 2023 Equity Incentive Plan to increase shares by 5,564,315 at the 2023-06-01 meeting.","evidence_excerpt":"The voting results of the Ordinary Shares were as follows: Votes For Votes Against Abstentions 21,822,290 2,726 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923067181/0001104659-23-067181-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-01"}],"fact_type":"shareholder_vote"},{"claim_id":"e13ec3cbe6c75ff5ef7ae01faa50ed6c154aa0ad","claim":"Zura Bio Ltd shareholders approved Private Placement Proposal - issuance of Ordinary Shares and Pre-Funded Warrants at the 2023-06-01 meeting.","evidence_excerpt":"The voting results of the Ordinary Shares were as follows: Votes For Votes Against Abstentions 18,511,602 481 6","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923067181/0001104659-23-067181-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-01"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}